,,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['trastuzumab', 'enhertu']
the use of trastuzumab deruxtecan (enhertu ), a new her2-targeting antibody-drug conjugate, doubled progressi... 
Physician-Scientist; Translational Oncologist https://t.co/8RMRruPhfx Director @BrownUCancer Associate Dean @BrownMedicine